Table 2.
Control (n = 285) | Group 1A (n = 37) | Group 1B (n = 43) | Group 2A (n = 70) | Group 2B (n = 60) | p-value | Total (n = 495) | |
---|---|---|---|---|---|---|---|
All eyes | |||||||
CMT (μm ± SD) | 267.29 ± 24.44 | 445.89 ± 133.11* | 532.47 ± 161.65*† | 336.21 ± 82.93*†‡ | 408.22 ± 106.32*‡§ | < 0.001 | 330.50 ± 117.30 |
SFCT (μm ± SD) | 273.41 ± 95.82 | 320.89 ± 71.97* | 310.70 ± 82.04 | 296.14 ± 87.52 | 279.25 ± 100.16 | 0.006 | 284.12 ± 93.54 |
Eyes with pachychoroid | |||||||
CMT (μm ± SD) | 265.92 ± 24.57 | 431.00 ± 139.97* | 500.48 ± 169.68*† | 345.38 ± 80.82*†‡ | 402.95 ± 105.92*‡§ | < 0.001 | 340.90 ± 124.80 |
SFCT (μm ± SD) | 374.33 ± 56.20 | 360.08 ± 35.11 | 357.59 ± 56.74 | 370.56 ± 55.67 | 388.14 ± 70.68 | 0.297 | 371.28 ± 55.82 |
*Statistically significant (p < 0.05) compared to control group
†Statistically significant (p < 0.05) compared to group 1A
‡Statistically significant (p < 0.05) compared to group 1B
§Statistically significant (p < 0.05) between group 2A vs 2B
SD standard deviation
One-way ANOVA and post hoc tests (CMT, SFCT) were used
Bold values denote statistical significance (p < 0.05)